Monosomy for the X-chromosome is associated with an atherogenic lipid profile

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 8, 2006, Pages 2867-2870

  Van, Phillip L ^a   Bakalov, Vladimir K ^a   Bondy, Carolyn A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHROMOSOME DAMAGE; CONTROLLED STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MONOSOMY; NUCLEAR MAGNETIC RESONANCE; OVARY INSUFFICIENCY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; TURNER SYNDROME; X CHROMOSOME;

EID: 33747738505     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0503     Document Type: Article

References (23)

1. Gardner CD, Winkleby MA, Fortmann SP 2000 Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988-1994). Am J Cardiol 86:299-304
2. Zhang J, Muldoon MF, McKeown RE 2004 Serum cholesterol concentrations are associated with visuomotor speed in men: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 80:291-298
3. Nikkila M, Pitkajarvi T, Koivula T, Solakivi T, Lehtimaki T, Laippala P, Jokela H, Lehtomaki E, Seppa K, Sillanaukee P 1996 Women have a larger and less atherogenic low density lipoprotein particle size than men. Atherosclerosis 119:181-190
4. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PW, Schaefer EJ 1987 Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis 7:483-490
5. Li Z, McNamara J, Fruchart J, Luc G, Bard J, Ordovas J, Wilson P, Schaefer E 1996 Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res 37:1886-1896
6. Barzilai N, Atzmon G, Schechter C, Schaefer EJ, Cupples AL, Lipton R, Cheng S, Shuldiner AR 2003 Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 290:2030-2040
7. Devroey D, De Swaef N, Coigniez P, Vandevoorde J, Kartounian J, Betz W 2004 Correlations between lipid levels and age, gender, glycemia, obesity, diabetes, and smoking. Endocr Res 30:83-93
8. Ford ES, Giles WH, Dietz WH 2002 Prevalence of the metabolic syndrome among U.S. adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287:356-359
9. 1995 Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 273:199-208
10. Stevenson JC, Oladipo A, Manassiev N, Whitehead MI, Guilford S, Proudler AJ 2004 Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers. Br J Haematol 124:802-808
11. Foster W, Lip GYH 2004 Hormone replacement therapy and cardiovascular disease: does route of administration and formulation matter? Br J Haematol 124:836-840
12. Schaefer EJ, Lamon-Fava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP, Wilson PW 1994 Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res 35:779-792
13. Gravholt CH, Juul S, Naeraa RW, Hansen J 1998 Morbidity in Turner syndrome. J Clin Epidemiol 51:147-158
14. Gravholt CH 2002 Turner syndrome and the heart: cardiovascular complications and treatment strategies. Am J Cardiovasc Drugs 2:401-413
15. Brown CJ, Greally JM 2003 A stain upon the silence: genes escaping X inactivation. Trends Genet 19:432-438
16. Carrel L, Willard HF 2005 X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434:400-404
17. Cooley M, Bakalov V, Bondy CA 2003 Lipid profiles in women with 45,X vs 46,XX primary ovarian failure. JAMA 290:2127-2128
18. Williams PT, Superko HR, Haskell WL, Alderman EL, Blanche PJ, Holl LG, Krauss RM 2003 Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol 23:314-321
19. Asztalos BF, Schaefer EJ 2003 High-density lipoprotein subpopulations in pathologic conditions. Am J Cardiol 91:12-17
20. Bakalov VK, Cooley MM, Quon M, Luo ML, Yanovski JA, Nelson LM, Bondy CA 2004 Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 89:3516-3520
21. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410
22. Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Agostino RB, Wilson PW, Schaefer EJ 2004 Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem 50:1189-1200
23. Rawson RB, Zelenski NG, Nijhawan D, Ye J, Sakai J, Hasan MT, Chang TY, Brown MS, Goldstein JL 1997 Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol Cell 1:47-57